Trial | NCT01981083  Report issue

Title

Egg Albumin-Based Protein Supplement Versus Renal-specific Supplement in Hemodialysis Patients
Randomized, Open Label, Controlled Clinical Trial of Egg Albumin-Based Protein Supplement Versus Renal Specific Oral Supplement in Hemodialysis Patients

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Unknown status

  • Study Participants

    60
Malnutrition is seen frequently in hemodialysis units in most developing countries. Malnutrition increases morbidity and mortality in this population and its treatment improves patient survival and health status The purpose of this study is to compare two strategies to improve nutritional status in hemodialysis patients: renal-specific oral supplement (237 ml) versus egg albumin-based protein supplement (30 g) on a daily basis.

This trial uses the Malnutrition Inflammation Score (MIS) and Subjective Global Assessment (SGA) in addition to most used biochemical markers to determine nutritional status.
Study Started
Nov 30
2013
Primary Completion
Nov 30
2014
Anticipated
Last Update
Nov 11
2013
Estimate

Dietary Supplement Egg albumin-based protein supplement

  • Other names: Pure ProEgg

Dietary Supplement Renal-specific oral supplement

  • Other names: Enterex Renal

Egg albumin-based protein supplement Experimental

Powder form, dosage 30 g daily, duration 6 months

Renal-specific oral supplement Active Comparator

Liquid form, dosage 237 ml (one can) daily, duration 6 months

Criteria 

Inclusion Criteria:

Chronic Kidney Disease in Hemodialysis

Exclusion Criteria:

Infection
Liver insufficiency
Cancer or neoplasia
Acquired immunodeficiency syndrome
Intestinal malabsorption syndrome
No Results Posted